# US 2025/0152966 A1 · Light therapy with biomarker feedback loop

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0152966 A1
- Document ID: US20250152966A1
- Status: Published application
- Kind: A1
- Application number: 19/021,301
- Filed: 2025-01-15
- Published: 2025-05-15
- Earliest claimed: 2020-09-21
- Assignees: Reversal Solutions, Inc.
- Applicants: Reversal Solutions, Inc.
- Inventors: Annelise E. Barron; John A. Fortkort; Peter A. Newsom
- Web page: https://patentgrep.com/patent/US20250152966A1

## CPC

- A61N 5/0613: {Apparatus adapted for a specific treatment}
- A61N 5/0618: {Psychological treatment}
- A61B 2018/00404: {Blood vessels other than those in or around the heart}
- A61N 2005/0632: {Constructional aspects of the apparatus}
- A61N 2005/0633: {Arrangements for lifting or hinging the frame which supports the light sources}
- A61N 2005/0635: {characterised by the body area to be irradiated}
- A61N 2005/0643: {Applicators, probes irradiating specific body areas in close proximity}
- A61N 2005/0659: {infrared}
- A61N 2005/0662: {Visible light}
- A61N 2005/0663: {Coloured light}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method is provided for treating a plaque-based arterial occlusion in a carotid artery of a subject. The method includes performing a carotid endarterectomy on the subject; determining the levels in the subject of a plurality of biomarkers Bi∈[B1, . . . , Bn], wherein n ≥2; and performing light therapy on the subject if any of the plurality of biomarkers Bi has a level xi in excess of a corresponding threshold value ti.

## Claims

### Claim 1

A method for treating a plaque-based arterial occlusion in a carotid artery of a subject, the method comprising:
performing a carotid endarterectomy on the subject;
determining the levels in the subject of a plurality of biomarkers Bi∈[B1, . . . , Bn], wherein n≥2; and
performing light therapy on the subject if any of the plurality of biomarkers Bi has a level xi in excess of a corresponding threshold value ti.

### Claim 2 (depends on 1)

The method of claim 1, wherein the light therapy is performed within 8 hours of the surgery.

### Claim 3 (depends on 1)

The method of claim 1, wherein the light therapy is performed within 6 hours of the surgery.

### Claim 4 (depends on 1)

The method of claim 1, wherein the light therapy is performed within 4 hours of the surgery.

### Claim 5 (depends on 1)

The method of claim 1, wherein the light therapy is performed within 2 hours of the surgery.

### Claim 6 (depends on 1)

The method of claim 1, wherein the light therapy is performed within 1 hour of the surgery.

### Claim 7 (depends on 1)

The method of claim 1, wherein the light therapy is performed prior to the surgery.

### Claim 8 (depends on 1)

The method of claim 1, comprising:
performing light therapy on the subject a first time; and
performing light therapy on the subject a second time if any of the plurality of biomarkers Bi has a level xi in excess of a corresponding threshold value ti.

### Claim 9 (depends on 1)

The method of claim 1, wherein the plurality of biomarkers is selected from the group consisting of cytokines and chemokines.

### Claim 10 (depends on 9)

The method of claim 9, wherein the at least one biomarker is selected from the group consisting of IL6, IL8, CCL3, CCL8 and CXCL6.

### Claim 11 (depends on 9)

The method of claim 9, wherein the at least one biomarker is a cytokine selected from the group consisting of IL6 and IL8.

### Claim 12 (depends on 9)

The method of claim 9, wherein the at least one biomarker is a chemokine selected from the group consisting of CCL3, CCL8 and CXCL6.

### Claim 13 (depends on 1)

The method of claim 1, wherein the light therapy includes PBMT.

### Claim 14 (depends on 1)

The method of claim 1, wherein the light therapy is used in conjunction with auditory stimulation.

### Claim 15 (depends on 1)

The method of claim 1, wherein the light therapy is used in conjunction with binaural beats.

### Claim 16

A method for treating a plaque-based arterial occlusion in a carotid artery of a subject, the method comprising:
performing a carotid endarterectomy on the subject;
determining in a subject the levels Li1 and Li2 at corresponding times ti1 and ti2 of a plurality of biomarkers Bi∈[B1, . . . , Bn], wherein n≥2; and
performing light therapy if, for at least one biomarker Bi, Δi≥ki, wherein Δi=Li2−Li1.

### Claim 17 (depends on 16)

The method of claim 16, wherein the light therapy is performed within 8 hours of the surgery.

### Claim 18 (depends on 16)

The method of claim 16, wherein the light therapy is performed within 6 hours of the surgery.

### Claim 19 (depends on 16)

The method of claim 16, wherein the light therapy is performed within 4 hours of the surgery.

### Claim 20 (depends on 16)

The method of claim 16, wherein the light therapy is performed within 2 hours of the surgery.
